RxDoctor Payments Data

Jan Smolen

Foot Surgery · Muskegon, MINPI 1407813413

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,796 of the $1,966 with a category attached, or 91.4%. DJO, LLC accounts for 91.4% of it on its own, with 5 other manufacturers making up the rest.

$1,966in general payments, 2019–2025

Across 85 payments — averaging $23.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • DJO, LLC$2K
  • Comsort, Inc$100
  • Johnson & Johnson$23
  • Treace Medical Concepts, Inc.$17
  • Osteomed LLC$15
  • Orthofix Medical, Inc.$15

What the payments were for

  • Consulting fees$1005%
  • Speaking & faculty fees$1,79691%
  • Food & beverage$543%
  • Education$151%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
DJO, LLC78$1,796
Comsort, Inc1$100
Johnson & Johnson1$23
Treace Medical Concepts, Inc.1$17
Osteomed LLC1$15
Orthofix Medical, Inc.3$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,966 in reported general payments places this provider in the 60th percentile of 22 foot surgery providers in Michigan.

See all foot surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$37,899
Medicare patients
139
Services billed
430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Imiquimod15$528
Cefdinir11$129
Cephalexin11$50

Paid to pharmacies, not to this prescriber.

Other foot surgery in Muskegon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →